# PPG Project 3 - PET/MRI of the Brain-hematopoiesis-atherosclerosis Axis in PTSD Patients

> **NCT03279393** · EARLY_PHASE1 · COMPLETED · sponsor: **Zahi Fayad** · enrollment: 190 (actual)

## Conditions studied

- PTSD
- Trauma
- Healthy

## Interventions

- **DRUG:** fluorodeoxyglucose (FDG)-PET/MRI

## Key facts

- **NCT ID:** NCT03279393
- **Lead sponsor:** Zahi Fayad
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-28
- **Primary completion:** 2023-02-14
- **Final completion:** 2023-02-14
- **Target enrollment:** 190 (ACTUAL)
- **Last updated:** 2023-04-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03279393

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03279393, "PPG Project 3 - PET/MRI of the Brain-hematopoiesis-atherosclerosis Axis in PTSD Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03279393. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*